Шкірні побічні ефекти онкологічного лікування Частина II. Променева терапія
DOI:
https://doi.org/10.30978/UJDVK2018-4-70Ключові слова:
променева терапія, побічні ефекти, радіаційний дерматит, радіаційні опіки, місцеві запальні реакції в зонах опромінення, індукований радіацією фіброз, профілактика, лікуванняАнотація
роменева терапія (ПТ) разом із хіміотерапією є способом лікування хворих зі злоякісними пухлинами. Так само, як і хіміотерапія, ПТ індукує виникнення побічних реакцій з боку шкіри, тяжкість яких значно варіюється, залежно від різних чинників, пов’язаних із лікуванням, таких як загальна доза, наявність чи відсутність фракціонування індивідуальної чутливості пацієнтів. Ці побічні реакції можуть бути гострими, що виникають відразу після проведення ПТ, пролонгованими, які розвиваються через деякий час після припинення процедури, або хронічними, і в цьому випадку можуть тривати багато років і навіть протягом усього життя. Найбільш часті гострі побічні реакції ПТ — гострий променевий дерматит, радіаційні опіки та місцеві запальні реакції в зонах опромінення. Найпоширенішою непрямою реакцією є індукований радіацією фіброз, а серед хронічних побічних ефектів найчастіше спостерігається хронічний променевий дерматит. Окрім профілактичних заходів, ефективність яких обмежена, менеджмент і лікування визнані обов’язковими й мають бути добре відомими дерматологам. Призначення цих процедур залежить від характеру та вираженості побічних реакцій. Цей огляд має на меті поглибити знання про побічні реакції з боку шкіри при ПТ та допомогти хворим, які звертаються по допомогу до фахівця.Посилання
Hall E, Cox J. Physical and biological basis of radiation therapy / Cox J, Ang K, editors. Radiation oncology. St. Louis; Mosby, 2003:3-62.
Hymes SR, Strom EA, Fife C. Radiation dermatitis: clinical presentation, pathophysiology, and treatment. J Am Acad Dermatol. 2006;54(1):28-46.
Bernier J, Bonner J, Vermorken JB, et al. Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. Ann Oncol. 2008;19:142-149.
Osako T, Ogushi M, Kumada M, et al. Acute Radiation Dermatitis and Pneumonitis in Japanese Breast Cancer Patients with Whole Breast Hypofractionated Radiotherapy Compared to Conventional Radiotherapy. Jpn J Clin Oncol. 2008;38(5):334-338.
McDonald MW, Godette KD, Butker EK, et al. Long-term outcomes of IMRT for breast cancer: a single-institution cohort analysis. Int J Radiat Oncol Biol Phys. 2008;72(4):1031-1040.
Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000;48:7-16.
Krasin MJ, Hoth KA, Hua C, et al. Incidence and correlates of radiation dermatitis in children and adolescents receiving radiation therapy for the treatment of paediatric sarcomas. Clin Oncol. (R Coll Radiol). 2009;21(10):781-785.
Ryan JL, Bole C, Hickok JT, et al. Post-treatment skin reactions reported by cancer patients differ by race, not by treatment or expectations. Br J Cancer. 2007;97(1):14-21.
Adelstein DJ, Li Y, Adams GL, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003;21:92-98.
Elliott EA, Wright JR, Swann RS, et al. Phase III trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Trial. 99-13. J Clin Oncol. 2006;24:2092-2097.
Dorr W, Hendry JH Consequential late effects in normal tissues. Radiother Oncol. 2001;6 1:223-231.
Common Terminology Criteria for Adverse Events v3.0 (CTCAE). http://ctep.cancer.gov/forms/CTCAEv3.pdf.
Carrotte-Lefebvre I, Delaporte E, Mirabel X. et al. Radiation-induced skin reactions (except cancers). Bull Cancer. 2003;90(4):319-325.
Bourhis J, Lapeyre M, Tortochaux J, et al. Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial. J Clin Oncol. 2006;24:2873-2878.
Muller K, Meineke V. Radiation-induced alterations in cytokine production by skin cells. Exp Hematol. 2007;35:96-104.
Isoir M, Buard V, Gasser P, et al. Human keratinocyte radiosensitivity is linked to redox modulation. J Dermatol Sci. 2006;41(1):55-65.
Peter RU, Beetz A, Ried C, et al. Increased expression of the epidermal growth factor receptor in human epidermal keratinocytes after exposure to ionizing radiation. Radiat Res. 1993;136:65-70.
Waghmare CM. Radiation burn - from mechanism to management. Burns. 2013;39(2):212-219.
Peter RU. Cutaneous radiation syndrome in multiorgan failure. Br. J. Radiol. 2005;27(Suppl.):180-184.
Burris HA, Hurtig J. Radiation recall with anticancer agents. Oncologist. 2010;15(11):1227-1237.
Anonymous. Effects of ionizing radiation on human skin. Clefs CEA. 2003;48.
Calle R, et al. Conservative management of operable breast cancer: ten years experience at the Fondation Curie. Cancer. 1978;42:2045-2053.
Habibollaki F, et al. Assessment of skin dose and its relation to cosmesis in the conservative treatment of early breast cancer. Int J Radiot Oncol Biol Phys. 1988;14:291-296.
Levit SH, et al. Breast Cancer. Principles and practice of radiation oncology, edited by CA Perez & LW Brandy, JB Lippincott. 1987:730-792.
Borger JH, et al. Dose and volume effects on fibrosis after breast conservation therapy. Int J Radiot Oncol Biol Phys. 1994;30:1073-1081.
Felhauer, et al. Late effects and cosmetic results of conventional versus hypofractionated irradiation in breast-conserving therapy. Strahlenther Onkol. 2005;181(10):625-631.
Raiyawa, et al. Late effects and cosmetic results of simultaneous integrated boost versus sequential boost after conventional irradiation in breast-conserving therapy: outcome of 7 months follow-up. J Med Assoc Thai. 2009;92(3):390-397.
Basu J, et al. Normal tissue complication probability of fibrosis in radiotherapy of breast cancer: accelerated partial beam irradiation vs. conventional external-beam radiotherapy. J Cancer Res Ther. 2008;4(3):126-130.
Hepel JT, et al. Toxicity of three-directional conformal radiotherapy for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2009;75(5):1290-1296.
Wadasadawala T, et al. Accelerated partial-breast irradiation vs. conventional whole breast radiotherapy in early breast cancer: a case-control study of disease control, cosmesis, and complications. J Cancer Res Ther. 2009;5(2):93-101.
Veronesi U, et al. Full-dose intraoperative radiotherapy with electrons during breast conserving surgery. Ann Surg. 2005;242(1):101-106.
Mussari S, et al. Full-dose intraoperative radiotherapy withelectrons in breast cancer. First report on late toxicity and cosmetic results from a single-institution experience. Strahlenther Onkol. 2006;182(10):589-595.
Kraus-Tiefenbacher U, et al. Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery. Int J Radiat Oncol Biol Phys. 2006;66(2):377-381.
Fleck R, et al. Consequences of breast irradiation in patients with pre-existing collagen vascular diseases. Int J Radiot Oncol Biol Phys. 1989;1 7:829-833.
Rubin P. et al. A perpetual cascade of cytokines post-irradiation leads to pulmonary fibrosis. Int J Radiot Oncol Biol Phys. 1995;33(1):99-109.
Rube CE, et al. Dose dependent induction of transforming growth factor β in the lung tissue of fibrosis-prone mice after thoracic irradiation. Int J Radiot Oncol Biol Phys. 2000;47(4):1033-1042.
Lilla C, et al. Predictive factors for late normal tissue complications following radiotherapy for breast cancer. Breast Cancer Res Treat. 2007;106(1):143-150.
Turesson I. Individual variation and dose dependency in the progression rate of skin telangiectasia. Int J Radiot Oncol Biol Phys. 1990;1 9:1569-1574.
Toledano A, et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study. Int J Radiat Oncol Biol Phys. 2006;65(2):324-332.
Roberts A, et al. Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA. 1986;83:4167-4171.
Brandes ME, et al. Transforming growth factor β1 suppresses acute and chronic arthritis in experimental animals. J Clin Invest. 1991;87:1108-1113.
Fajardo LF, et al. Morphology of radiation effects on normal tissues. Perez CA, Brady LW (eds): Principles and practice of radiation oncology.— Philadelphia: PA, JB Lippincott Company, 1992;2:114-123.
Border W. Fibrosis linked to TGF-β is yet another disease. J Clin Invest. 1995;96:655-656.
Moses HL, et al. TGF-production by chemically transformed cells. Cancer Res. 1981;41:2842-2848.
Perkins JL, Liu Y, Mitby PA, et al. Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2005;23(16):3733-41.
Ron E, Modan B, Preston D, Alfandary E, et al. Radiation-induced skin carcinomas of the head and neck. Radiat Res. 1991;125(3):318-325.
Roy I, Fortin A, Larochelle M. The impact of skin washing with water and soap during breast irradiation: a randomized study. Radiother Oncol. 2001;58(3):333-339.
Bernier J, Bonner J, Vermorken JB, et al. Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. Ann Oncol. 2008;19(1):142-149.
Miller RC, Schwartz DJ, Sloan JA, et al. Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4. Int J Radiat Oncol Biol Phys. 2011;79(5):1460-1466.
Potera ME, Lookingbill DP, Stryker JA. Prophylaxis of radiation dermatitis with a topical cortisone cream. Radiology. 1982;143(3):775-777.
Bostrom A, Lindman H, Swartling C. et al. Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study. Radiother Oncol. 2001;59(3):257-265.
Dale PS, Tamhankar CP, George D, et al. Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects. Cancer Chemother Pharmacol. 2001;47(Suppl.):29-34.
Margolin SG, Breneman JC, Denman DL, et al. Management of radiation-induced moist skin desquamation using hydrocolloid dressing. Cancer Nurs. 1990;13(2):71-80.
Kedge EM. A systematic review to investigate the effectiveness and acceptability of interventions for moist desquamation in radiotherapy patients. Radiography. 2009;15(3):247-257.
Manzanas García A, López Carrizosa MC, Vallejo Ocaña C, et al. Superoxide dismutase (SOD) topical use in oncologic patients: treatment of acute cutaneous toxicity secondary to radiotherapy. Clin Transl Oncol. 2008;10:163-167.
Bey E, Prat M, Duhamel P, et al. Emerging therapy for improving wound repair of severe radiation burns using local bone marrow-derived stem cell administrations. Wound Repair Regen. 2010;18(1):50-58.
Susser WS, Whitaker-Worth DL, Grant-Kels JM.Mucocutaneous reactions to chemotherapy. J Am Acad Dermatol. 1999;40(3):367-398.
Potter T, Hashimoto K. Cutaneous photosensitivity to medications. Compr Ther 1994;20:414-417.
Bourgeois JF, Gourgou S, Kramar A, et al. A randomized, prospective study using the LPG technique in treating radiation-induced skin fibrosis: clinical and profilometric analysis. Skin Res Technol. 2008;14(1):71-76.
Bray FN, Simmons BJ, Wolfson AH, et al. Acute and Chronic Cutaneous Reactions to Ionizing Radiation Therapy. Dermatol Ther (Heidelb). 2016;6(2):185-206.
Magnusson M, Hoglund P, Johansson K, et al. Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: a phase two, double-blind, placebo-controlled randomised clinical trial (Ptx‑5). Eur J Cancer. 2009;45(14):2488-2495.
Delanian S, Porcher R, Rudant J, et al. Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis. J Clin Oncol. 2005;23(34):8570-8579.
Perdereau B, et al. Superoxide dismutase (Cu/Zn) in cutaneous application in the treatment of radio-induced fibrosis. Bull. Cancer. 1994;81(8):659-669.
Benyahia, et al. Effects of superoxide dismutase topical treatment on human skin radiofibrosis: a pathological study. Breast. 1996;5:75-81.
Campana F, et al. Topical superoxide dismutase reduces post-irradiation breast cancer fibrosis. J Cell Mol Med. 2004;8(1):109-116.
Habibollaki F, et al. Assessment of skin dose and its relation to cosmesis in the conservative treatment of early breast cancer. Int J Radiot Oncol Biol Phys. 1988;14:291-296.
Vozenin-Brotons MC, Sivan V, Gault N, et al. Antifibrotic action of Cu/Zn SOD is mediated by TGF-b1. Repression and phenotypic reversion of myofibroblasts. Free Radical Biology & Medicine. 2001;30(1):30-42.
Gottlober P, Steinert M, Bahren W, et al. Interferon-gamma in. 5 patients with cutaneous radiation syndrome after radiation therapy. Int J Radiat Oncol Biol Phys. 2001;50(1):159-166.
Gothard L, Stanton A, MacLaren J, et al. Non-randomised phase II trial of hyperbaric oxygen therapy in patients with chronic arm lymphoedema and tissue fibrosis after radiotherapy for early breast cancer. Radiother Oncol. 2004;70(3):217-224.
Lanigan SW, Joannides T. Pulsed dye laser treatment of telangiectasia after radiotherapy for carcinoma of the breast. Br J Dermatol. 2003;148(1):77-79.
Rossi AM, Nehal KS, Lee EH. Radiation-induced breast telangiectasias treated with the pulsed dye laser. J Clin Aesthet Dermatol. 2014;7(12):34-37.
